<DOC>
	<DOC>NCT00098124</DOC>
	<brief_summary>Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia. The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.</brief_summary>
	<brief_title>Study of Milnacipran for the Treatment of Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) Criteria Psychiatric illness Depression Suicidal risk Substance abuse Pulmonary dysfunction Renal impairment Active cardiac disease Liver disease Autoimmune disease Cancer Sleep apnea Inflammatory bowel disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>NSRI</keyword>
	<keyword>milnacipran</keyword>
	<keyword>fibromyalgia</keyword>
</DOC>